Clinical Trial Update: Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer [Phase 1]

View source ↗

Summary

Phase 1 study assessing the test–retest reliability of the novel PET tracer [11C]PF-06809247 for neuroinflammation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroinflammation

Drugs mentioned

• [11C]PF-06809247 (PF-06809247)

Snippet

Sponsor: Pfizer | Conditions: Neuroinflammation | Phase 1 | Status: COMPLETED